September 11, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Biomere | a JOINN company - Boston area preclinical CRO services to accelerate Go/No-Go Decisions using reliable ADME, early toxicology and efficacy data. Connect with us.
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
CONTINUING NEXT WEEK!
Due to the Labor Day holiday, we will have our next CEO Q&A next week with Manish Arora, Founder and CEO, LinusBio - check out our previous Q&As here

Press Releases

  • Dana-Farber Cancer Institute: Launches New Platform to Bring Its Cancer Treatment Expertise Directly to Oncologists’ Clinical Workflow More
  • Eloxx Pharmaceuticals: First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome More
  • GENFIT: Will Join CAC Mid 60 and SBF 120 Indices on Euronext Paris More
  • New England Biolabs: 2026 Passion in Science Awards Recipients More

Financial News

CRCFO Advisory
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible.
Learn More  →
  • Entrada Therapeutics: Recipients of Fourth Annual DREAMS Grant Program More
  • More on Mass. Governor Making Pre-Election Pitch to Biotechs Amid Warning Early-Stage Start-Ups Are ‘Dying’ More
  • Vincere Biosciences: Awarded $2.7 Million NIH Grant to Advance USP30 Inhibitor for Acute Kidney Injury More

Media/Misc Coverage

Pace® Life Sciences

The CDMO That Takes You Further. Your partner for Product Development, Manufacturing, Analytical Testing, Regulatory Consulting & Operational Support.
Learn More  →
  • BioPharmGuy News: HIMplant, PSA3, Holmes Wrecker, Pink & the Brain More
  • Biotech & Pharma Updates | September 10, 2026 More
  • Boston Scientific Restores Operations After Cyber Attack Stymied Production for Over Two Weeks More*
  • Can We Teach the Body Where to Build Bone? The Future of Spinal Fusion | Jeffrey Frelick - CEO, Bone Biologics Podcast
  • Marine Biological Laboratory: Expands Board of Trustees as It Charts Its Next Chapter as an Independent Institution More
  • More on Disc Medicine Sharing Polycythemia Vera Data, Outlining Late 2026 Trial Milestones More
  • Subscribe to LifeSci Startup for Updates on US Startups More

Career Moves

Telling Your Science Story to Investors
Learn More  →
  • Candel Therapeutics: Appoints Martine Zimmermann, PharmD, to Its Board of Directors More
  • OPPORTUNITY: Chief Financial Officer, Boston/San Diego More
  • OPPORTUNITY: SVP, Regulatory and Quality Assurance, Boston/San Diego More
  • OPPORTUNITY: Head of Global Research & Development, Columbia, MD More
  • Slone Partners: Behind the Search’ - A Conversation with George Quinn, Partner, Fractional Talent More
  • Slone Partners: ICYMI - How to Keep Your Highest Performers Engaged More
  • Takeda: Planned Retirement of President of Research & Development Andy Plump More More More More*
  • TransCode Therapeutics: Leadership Transition More
  • TransMedics: Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook More

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: BioFuture Oct 27-28
Learn More  →

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: Boston Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

Boston Sponsors

Follow us

Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:Boston, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.